The Quest to Save American-Made Antibiotics

This podcast episode examines the fate of the Bristol amoxicillin plant, detailing its history, decline, and the heroic efforts of Rick Jackson to revitalize it as US Antibiotics, emphasizing the critical issues surrounding the sustainability of American drug manufacturing and the impacts of global competition on national health security.

Outlines

Sign in to continue reading, translating and more.

Continue

The Journal.

The Amoxicillin Shortage: A Crisis in American Drug Manufacturing

A Plant's Decline and Rick Jackson's Rescue Mission

The Challenges of Revitalizing American Drug Manufacturing

The Economics of Generic Drugs and the Role of Government

Rick Jackson's Vision for the Future of US Antibiotics

The Broader Implications of Drug Shortages

The Quest to Save American-Made Antibiotics

The Journal.

00:04The Amoxicillin Shortage: A Crisis in American Drug Manufacturing

The Amoxicillin Shortage: A Crisis in American Drug Manufacturing

05:20A Plant's Decline and Rick Jackson's Rescue Mission

A Plant's Decline and Rick Jackson's Rescue Mission

09:32The Challenges of Revitalizing American Drug Manufacturing

The Challenges of Revitalizing American Drug Manufacturing

12:29The Economics of Generic Drugs and the Role of Government

The Economics of Generic Drugs and the Role of Government

14:51Rick Jackson's Vision for the Future of US Antibiotics

Rick Jackson's Vision for the Future of US Antibiotics

16:49The Broader Implications of Drug Shortages

The Broader Implications of Drug Shortages